Pretreatment (18)F‐FDG Uptake Heterogeneity Predicts Treatment Outcome of First‐Line Chemotherapy in Patients with Metastatic Triple‐Negative Breast Cancer

BACKGROUND. Intratumoral heterogeneity of (18)F‐fluorodeoxyglucose ((18)F‐FDG) uptake in primary tumor has proven to be a surrogate marker for predicting treatment outcome in various tumors. However, the value of intraindividual heterogeneity in metastatic diseases remains unknown. The aim of this s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Gong, Chengcheng, Ma, Guang, Hu, Xichun, Zhang, Yingjian, Wang, Zhonghua, Zhang, Jian, Zhao, Yannan, Li, Yi, Xie, Yizhao, Yang, Zhongyi, Wang, Biyun
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2018
Assuntos:
Breast Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6263118/
https://ncbi.nlm.nih.gov/pubmed/30082489
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados